NuGene International Inc (OTCBB:NUGN) continues to trade in multi-dollar land on significant volume as the promotion carries on. NUGN initially ran as high as $4.55 a share before gravity set in and the stock began to flounder.
NUGN is a $2.28 million 28-page glossy hard mailer promotion featuring Kathy Ireland and the headline ”Did Kathy Ireland just discover Botox without the needle? Super model Kathy Ireland sells an estimated $2b at retail annually and just partnered with NUGN.”” it then makes the preposterous prediction that ”shares could fly from $1.27 to $25.08.”
According to the disclaimer ”Casson Media Group, Inc. (CMG), an affiliated company of MicroCap MarketPlace has received nine thousand dollars in cash compensation from Result Corporation, a third party shareholder of NUGN to assist in the writing of this Advertisement, and anticipates receiving potential future subscription and advertising revenues, the amount of which is not known and cannot be predicted at this time. Result Corporation, besides compensating CMG, paid two million two hundred and eighty thousand dollars to marketing vendors to cover all the costs of creating and distributing this Advertisement, including printing and postage, in an effort to build investor and market awareness.
NuGene International Inc (OTCBB:NUGN) bills itself as a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media.
According to NUGN the US Department of Health and Human Services calls regenerative medicine the “next evolution of medical treatments.” The regenerative medical market, which includes cosmeceuticals and pharmaceuticals, was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report.
NuGene’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company has two patents pending covering 15 unique applications and inventions. NuGene’s goal is to leverage its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.
To Find out the inside Scoop on NUGN Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On June 11 NUGN announced it is initiating a study that will allow NuGene to evaluate a medication formulation as an improved method of treating burn wounds.
The study, named Comparison of an Allantoin Formulation and Allantoin Formulation with Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing Protocol, will begin immediately and is scheduled to run through September 1, 2015 but may be extended if necessary.
NuGene will provide the investigational new drug to be used in this study. The study will compare the effect of using Allontoin, a natural chemical compound that is produced by many organisms and is commonly used as an ingredient in skin care products, both with and without NuGene’s proprietary conditioned media of adipose-derived stem cells.
Also of importance here (thanks to Hotstocked) is the 148,200 shares of Bling Marketing that were acquired on March 27, 2014 for just $37,050. After the forward splits these shares are now 11,144,640 free trading shares of NUGN.
According to Hotstocked ”It all started in March 2014 when some investors bought a total of 148,200 shares at $0.25 apiece for $37,050. After two forward splits these shares turned into 11,144,640 free trading shares of NUGN common stock. These are most likely the shares being liquidated into the promotion.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $80 million market valuation NUGN does have $1.3 million in the treasury and growing revenues reporting $723,438 in sales in 2014. While NUGN is down from its initial highs it still commands a price well over $1 on the $2.28 million 28-page glossy hard mailer promotion featuring Kathy Ireland. Short term NUGN could move higher, long term the stock has no real fundamentals to back up anywhere near current valuation and could drop big. We will be updating on NUGN when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NUGN.
WAIT! Do You Want Stocks That Could Go Up 348% In Days Delivered To Your Inbox For FREE?
Disclosure: we hold no position in NUGN either long or short and we have not been compensated for this article.
NUGN preposterous Hard Mailer